Study: Ecstacy may be useful in PTSD therapy

Researchers believe they have found the next step in PTSD therapy: MDMA--commonly known as ecstacy--usage in therapeutic environments. In a recent Phase II study published in Journal of Psychopharmacology, psychologists found using MDMA during PTSD therapy sessions allowed patients to better manage and understand their emotions than with traditional therapy methods alone. Report

Suggested Articles

MicuRx nabbed $7.78 million from a nonprofit focused on antimicrobial resistance to push its third antimicrobial program into human trials.

The FDA has handed Scholar Rock a rare pediatric disease designation voucher, which can allow the biotech a speedy review of its SMA med.

The FDA has placed a phase 1/2 trial of Passage Bio’s GM1 gene therapy on clinical hold pending further assessment of the risk of its delivery device.